Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DMR) discontinuing dasatinib (DASFREE) Meeting Abstract
| Authors: | Shah, N. P.; Garcia-Gutiérrez, J. V.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Pane, F.; Nicolini, F. E.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H. |
| Abstract Title: | Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DMR) discontinuing dasatinib (DASFREE) |
| Meeting Title: | 6th Annual Meeting of the Society of Hematologic Oncology (SOHO 2018) |
| Keywords: | inhibitor; dasatinib; chronic myeloid leukemia; tyrosine kinase; discontinuation; treatment-free remission |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 18 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Sep 12-15 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-09-01 |
| Start Page: | S220 |
| End Page: | S221 |
| Language: | English |
| ACCESSION: | WOS:000444343400140 |
| DOI: | 10.1016/j.clml.2018.07.090 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CML-044 -- Source: Wos |
